Rikard Holmdahl Selected Research

Monoclonal Antibodies

5/2022	Characterization of chronic relapsing antibody mediated arthritis in mice with a mutation in Ncf1 causing reduced oxidative burst.
1/2018	Chronic Active Arthritis Driven by Macrophages Without Involvement of T Cells: A Novel Experimental Model of Rheumatoid Arthritis.
6/2011	Chemical changes demonstrated in cartilage by synchrotron infrared microspectroscopy in an antibody-induced murine model of rheumatoid arthritis.
11/2010	Specific antibody protection of the extracellular cartilage matrix against collagen antibody-induced damage.
1/2007	Collagen antibody induced arthritis.
1/2006	Type IX collagen deficiency enhances the binding of cartilage-specific antibodies and arthritis severity.
9/2005	Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis.
3/2005	The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.
1/2005	Destructive effects of murine arthritogenic antibodies to type II collagen on cartilage explants in vitro.
7/2004	Antileukoproteinase: modulation of neutrophil function and therapeutic effects on anti-type II collagen antibody-induced arthritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rikard Holmdahl Research Topics

Disease

179	Arthritis (Polyarthritis) 04/2024 - 01/2002
137	Rheumatoid Arthritis 04/2024 - 02/2002
81	Experimental Arthritis 02/2024 - 05/2002
56	Inflammation (Inflammations) 04/2024 - 01/2002
39	Autoimmune Diseases (Autoimmune Disease) 04/2024 - 01/2002
12	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2023 - 10/2006
9	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2017 - 07/2002
7	Pain (Aches) 02/2024 - 12/2012
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2023 - 09/2002
7	Neoplasms (Cancer) 01/2022 - 10/2010
6	Psoriatic Arthritis 06/2023 - 09/2016
6	Infections 12/2022 - 09/2014
6	Hypersensitivity (Allergy) 01/2022 - 08/2004
6	Multiple Sclerosis 05/2017 - 01/2003
5	Pneumonia (Pneumonitis) 01/2023 - 04/2013
5	Chronic Granulomatous Disease 12/2014 - 11/2012
4	Necrosis 01/2021 - 08/2005
4	Colitis 03/2018 - 01/2014
4	Relapsing Polychondritis 03/2004 - 01/2002
3	Osteoarthritis 11/2022 - 09/2002
3	Chronic Disease (Chronic Diseases) 05/2022 - 08/2011
3	Pathologic Processes 09/2016 - 01/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 09/2011
2	Sepsis (Septicemia) 01/2023 - 07/2010

Drug/Important Bio-Agent (IBA)

93	Collagen Type II (Type II Collagen)IBA 06/2023 - 01/2002
64	AntibodiesIBA 11/2023 - 09/2002
45	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2002
41	CollagenIBA 12/2022 - 01/2002
40	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 09/2005
39	AutoantibodiesIBA 02/2024 - 09/2002
38	Peptides (Polypeptides)IBA 03/2024 - 01/2003
36	EpitopesIBA 01/2023 - 06/2002
33	pristane (pristan)IBA 01/2021 - 01/2002
27	AntigensIBA 03/2024 - 08/2005
26	Immunoglobulin G (IgG)IBA 02/2024 - 09/2002
21	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020 - 01/2003
18	CytokinesIBA 01/2023 - 10/2002
15	AutoantigensIBA 11/2023 - 01/2002
14	Anti-Citrullinated Protein AntibodiesIBA 02/2024 - 01/2010
13	neutrophil cytosolic factor 1IBA 04/2024 - 01/2003
13	MannansIBA 06/2023 - 09/2014
13	Monoclonal AntibodiesIBA 05/2022 - 09/2002
12	acetyl 4-aminosalicylic acidIBA 01/2023 - 01/2010
11	GlycopeptidesIBA 01/2018 - 12/2002
9	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2024 - 06/2002
9	Antigen-Antibody Complex (Immune Complex)IBA 11/2023 - 07/2004
9	Cartilage Oligomeric Matrix ProteinIBA 01/2022 - 01/2002
8	Polysaccharides (Glycans)IBA 12/2022 - 10/2007
8	Histocompatibility Antigens Class IIIBA 11/2012 - 01/2006
7	Rheumatoid FactorIBA 02/2024 - 12/2003
7	VaccinesIBA 01/2023 - 10/2010
7	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 12/2002
6	Immunoglobulin M (IgM)IBA 11/2023 - 12/2003
6	EnzymesIBA 11/2017 - 03/2006
5	NADPH Oxidase 2IBA 10/2023 - 05/2012
5	Amino Acids FDA Link 06/2023 - 09/2002
5	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 01/2023 - 01/2005
5	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022 - 01/2006
5	Oxygen (Dioxygen)IBA 01/2020 - 08/2007
5	Complement System Proteins (Complement)IBA 10/2013 - 03/2004
4	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2023 - 08/2015
4	Therapeutic UsesIBA 01/2023 - 07/2004
4	Collagen Type XIIBA 01/2020 - 05/2002
4	Glycoproteins (Glycoprotein)IBA 01/2020 - 01/2002
4	LipopolysaccharidesIBA 01/2020 - 11/2003
4	InterferonsIBA 01/2020 - 07/2013
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 01/2010
4	Mineral Oil (Liquid Paraffin)FDA LinkGeneric 11/2017 - 12/2007
4	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 11/2012 - 02/2007
4	NADP (NADPH)IBA 07/2012 - 09/2005
3	Cysteine (L-Cysteine)FDA Link 04/2024 - 10/2007
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2013
3	glycosylated collagenIBA 01/2022 - 07/2002
3	LipidsIBA 01/2021 - 11/2017
3	LigandsIBA 10/2020 - 08/2010
3	Interleukin-17 (Interleukin 17)IBA 01/2020 - 01/2017
3	NitrogenIBA 01/2020 - 09/2009
3	SodiumIBA 03/2018 - 08/2014
3	AsparagineIBA 01/2018 - 10/2007
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2017 - 01/2002
3	Proteoglycans (Proteoglycan)IBA 07/2017 - 06/2011
3	Estrogens (Estrogen)FDA Link 11/2016 - 11/2003
3	PolymersIBA 01/2016 - 11/2011
3	poly-N-isopropylacrylamideIBA 01/2016 - 11/2011
3	CitrullineIBA 10/2015 - 02/2009
3	Immunodominant EpitopesIBA 11/2014 - 01/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2006 - 02/2002
3	Myelin-Oligodendrocyte GlycoproteinIBA 08/2004 - 07/2002
2	Complement C5 (Complement 5)IBA 02/2024 - 09/2006
2	IgG Receptors (Fc gamma RI)IBA 02/2024 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 11/2023 - 01/2004
2	NucleotidesIBA 06/2023 - 06/2011
2	Arginine (L-Arginine)FDA Link 06/2023 - 11/2022
2	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2023 - 12/2015
2	Mitochondrial DNA (mtDNA)IBA 01/2023 - 12/2009

Therapy/Procedure

9	Therapeutics 01/2023 - 02/2002
4	Intraperitoneal Injections 06/2023 - 09/2005
4	Injections 05/2022 - 03/2005
3	Intravenous Injections 05/2022 - 07/2004
3	Transplantation 10/2010 - 06/2002